Matches in SemOpenAlex for { <https://semopenalex.org/work/W2193491176> ?p ?o ?g. }
- W2193491176 endingPage "2610" @default.
- W2193491176 startingPage "2596" @default.
- W2193491176 abstract "Telomere maintenance is a universal cancer hallmark, and small molecules that disrupt telomere maintenance generally have anticancer properties. Since the vast majority of cancer cells utilize telomerase activity for telomere maintenance, the enzyme has been considered as an anticancer drug target. Recently, rational design of telomerase inhibitors was made possible by the determination of high resolution structures of the catalytic telomerase subunit from a beetle and subsequent molecular modeling of the human telomerase complex. A hybrid strategy including docking, pharmacophore-based virtual screening, and molecular dynamics simulations (MDS) were used to identify new human telomerase inhibitors. Docking methodology was applied to investigate the ssDNA telomeric sequence and two well-known human telomerase inhibitors' (BIBR1532 and MST-312) modes of interactions with hTERT TEN domain. Subsequently molecular dynamic simulations were performed to monitor and compare hTERT TEN domain, TEN-ssDNA, TEN-BIBR1532, TEN-MST-312, and TEN-ssDNA-BIBR1532 behavior in a dynamic environment. Pharmacophore models were generated considering the inhibitors manner in the TEN domain anchor site. These exploratory studies identified several new potent inhibitors whose IC50 values were generated experimentally in a low micromolar range with the aid of biochemical assays, including both the direct telomerase and the telomeric repeat amplification protocol (TRAP) assays. The results suggest that the current models of human telomerase are useful templates for rational inhibitor design." @default.
- W2193491176 created "2016-06-24" @default.
- W2193491176 creator A5011114425 @default.
- W2193491176 creator A5026902416 @default.
- W2193491176 creator A5041868084 @default.
- W2193491176 creator A5060062951 @default.
- W2193491176 creator A5071446513 @default.
- W2193491176 date "2015-12-02" @default.
- W2193491176 modified "2023-09-24" @default.
- W2193491176 title "Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical Assays" @default.
- W2193491176 cites W1433609531 @default.
- W2193491176 cites W1502653371 @default.
- W2193491176 cites W1510708869 @default.
- W2193491176 cites W1514382612 @default.
- W2193491176 cites W1517051009 @default.
- W2193491176 cites W1543500873 @default.
- W2193491176 cites W1772181154 @default.
- W2193491176 cites W184964999 @default.
- W2193491176 cites W1964831810 @default.
- W2193491176 cites W1970770718 @default.
- W2193491176 cites W1977501444 @default.
- W2193491176 cites W1980470053 @default.
- W2193491176 cites W1990625302 @default.
- W2193491176 cites W1992041755 @default.
- W2193491176 cites W1996882901 @default.
- W2193491176 cites W1998335196 @default.
- W2193491176 cites W2000971601 @default.
- W2193491176 cites W2003487137 @default.
- W2193491176 cites W2014359205 @default.
- W2193491176 cites W2014482493 @default.
- W2193491176 cites W2015136221 @default.
- W2193491176 cites W2016672919 @default.
- W2193491176 cites W2018618511 @default.
- W2193491176 cites W2020066813 @default.
- W2193491176 cites W2020563521 @default.
- W2193491176 cites W2025615481 @default.
- W2193491176 cites W2027482274 @default.
- W2193491176 cites W2028350610 @default.
- W2193491176 cites W2030976397 @default.
- W2193491176 cites W2044062663 @default.
- W2193491176 cites W2045571168 @default.
- W2193491176 cites W2049792735 @default.
- W2193491176 cites W2053704023 @default.
- W2193491176 cites W2055100052 @default.
- W2193491176 cites W2058280701 @default.
- W2193491176 cites W2058743530 @default.
- W2193491176 cites W2064208421 @default.
- W2193491176 cites W2073792387 @default.
- W2193491176 cites W2077321072 @default.
- W2193491176 cites W2078263411 @default.
- W2193491176 cites W2078805336 @default.
- W2193491176 cites W2079378073 @default.
- W2193491176 cites W2085054662 @default.
- W2193491176 cites W2092476508 @default.
- W2193491176 cites W2095145930 @default.
- W2193491176 cites W2098085059 @default.
- W2193491176 cites W2101014559 @default.
- W2193491176 cites W2103483650 @default.
- W2193491176 cites W2105668062 @default.
- W2193491176 cites W2108503708 @default.
- W2193491176 cites W2109975152 @default.
- W2193491176 cites W2111458920 @default.
- W2193491176 cites W2114367386 @default.
- W2193491176 cites W2117824620 @default.
- W2193491176 cites W2117969511 @default.
- W2193491176 cites W2124310315 @default.
- W2193491176 cites W2132988092 @default.
- W2193491176 cites W2135055810 @default.
- W2193491176 cites W2137825366 @default.
- W2193491176 cites W2142087742 @default.
- W2193491176 cites W2143859021 @default.
- W2193491176 cites W2146609866 @default.
- W2193491176 cites W2149471694 @default.
- W2193491176 cites W2157004511 @default.
- W2193491176 cites W2160204767 @default.
- W2193491176 cites W2160544821 @default.
- W2193491176 cites W2160576740 @default.
- W2193491176 cites W2161541244 @default.
- W2193491176 cites W2161817637 @default.
- W2193491176 cites W2165948908 @default.
- W2193491176 cites W2166089777 @default.
- W2193491176 cites W2168083201 @default.
- W2193491176 cites W2169961966 @default.
- W2193491176 cites W2208203352 @default.
- W2193491176 cites W2321215089 @default.
- W2193491176 cites W4211144080 @default.
- W2193491176 cites W4237540956 @default.
- W2193491176 doi "https://doi.org/10.1021/acs.jcim.5b00336" @default.
- W2193491176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26529120" @default.
- W2193491176 hasPublicationYear "2015" @default.
- W2193491176 type Work @default.
- W2193491176 sameAs 2193491176 @default.
- W2193491176 citedByCount "20" @default.
- W2193491176 countsByYear W21934911762016 @default.
- W2193491176 countsByYear W21934911762017 @default.
- W2193491176 countsByYear W21934911762018 @default.
- W2193491176 countsByYear W21934911762019 @default.
- W2193491176 countsByYear W21934911762020 @default.